3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
2
Unknown
1
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Neoplasms
3
Motor Activity
3
Breast Neoplasms
2
Prostatic Neoplasms
1
Inflammation
1
Fatigue
1
Colorectal Neoplasms
1
Chemotherapy-Related Cognitive Impairment
1
Cachexia
1
Interventions
Fluorouracil
80
Oxaliplatin
72
Leucovorin
66
Irinotecan
61
Capecitabine
58
Bevacizumab
57
Cetuximab
43
Folfox protocol
22
Drug Therapy
22
Neoadjuvant Therapy
19
HMPL-013
17
Colonoscopy
17
regorafenib
15
apatinib
11
Panitumumab
11
Chemotherapy, Adjuvant
11
trifluridine tipiracil drug combination
10
XELOX
10
Laparoscopy
10
IFL protocol
10
sintilimab
9
raltitrexed
9
Radiotherapy
9
Blood Specimen Collection
9
Surveys and Questionnaires
8
Surgical Procedures, Operative
8
tislelizumab
7
pembrolizumab
7
Endoscopic Mucosal Resection
7
Aspirin
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Colorectal Neoplasms
×
High-Intensity Interval Training
×
Clear all
NCT02473003
2023-12-21
Phys-Can
Uppsala University
Phase NA
Unknown
600 enrolled